Quantcast
Last updated on April 16, 2014 at 6:35 EDT

Latest Medicago Stories

2011-11-16 13:04:00

Genome gives clues into legume evolution, and could provide means to better understand and better utilize closely related agricultural crops such as alfalfa ROCKVILLE, Md., Nov. 16, 2011 /PRNewswire-USNewswire/ -- Scientists from the J. Craig Venter Institute (JCVI), along with a team of international researchers led by those at the University of Minnesota, have sequenced and published a draft genome of the model legume, Medicago truncatula, also known by its common name, "barrel medic."...

2011-11-14 16:00:00

QUEBEC CITY, Nov. 14, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced its operational and financial results for the third quarter ended September 30, 2011. The Company's financial statements and management report are available at www.sedar.com and at www.medicago.com. "This was another quarter of progress on...

2011-11-10 06:00:00

RALEIGH, North Carolina and QUEBEC CITY, Quebec, Nov. 10, 2011 /PRNewswire/ - Medicago U.S.A. Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that company executives, along with North Carolina Governor Beverly Perdue, U.S. Senator Richard Burr and Congressman David Price, are holding an...

2011-11-09 10:02:00

QUEBEC CITY, Nov. 9, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Mr. Pierre Labbe, the Company's Chief Financial Officer, has been invited to present at the Lazard Capital Markets 8th Annual Healthcare Conference. The conference will be held at The Pierre Hotel in New York City on November 15-16,...

2011-10-12 06:00:00

- Receives Approval to Proceed to Second Stage of Agreement - QUEBEC CITY, Oct. 12, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced the successful completion of the first stage of its research collaboration, announced initially on April 6, 2011, with a top 10 global pharmaceutical company for the...

2011-09-13 06:00:00

-Operations begin within eleven months of hosting groundbreaking ceremony- RALEIGH, NC and Quebec City, Sept. 13, 2011 /PRNewswire/ - Medicago USA Inc., a wholly owned subsidiary of Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that it has commenced operations at its 97,000-square-foot plant-based vaccine facility in...

2011-08-23 06:30:00

-Prestigious recognition for Medicago's VLP vaccine technology platform- QUEBEC CITY, Aug. 23, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced it has won the 2011 Frost & Sullivan Enabling Technology of the Year award in the vaccine market. This award recognizes Medicago's achievements and...

2011-08-17 06:00:00

FIVE POINTS, Calif., Aug. 17, 2011 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW) today announced it is shipping its first commercial scale alfalfa seed order destined for the new country of North Sudan. The sale is for a selection of S&W's proprietary non-dormant, salt tolerant, seed alfalfa varieties that have been carefully chosen with a view to growing conditions in North Sudan. The Company is keenly interested in North and South Sudan because of their role in the Company's...

2011-06-22 06:00:00

- 2011 "Prix Sant©" presented by the Armand-Frappier Foundation - - 2011 Genesis Entrepreneurship Award presented by BIOQuebec - QUEBEC CITY, June 22, 2011 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), announced today that it was named this month both the recipient of the 2011 "Prix Sant©" awarded by the...

2011-06-21 06:30:00

FIVE POINTS, Calif., June 21, 2011 /PRNewswire/ -- S&W Seed Company (Nasdaq: SANW), announced today the retention of Lytham Partners, LLC to conduct a national investor relations program. Mark S. Grewal, president and CEO of S&W Seed Company, commented, "S&W is now firmly positioned in three markets: production and marketing of high salt- and heat-tolerant alfalfa seed, the natural sweetener market via our new stevia planting program, and seed cleaning and processing for...